43
Participants
Start Date
April 22, 2024
Primary Completion Date
September 5, 2024
Study Completion Date
September 5, 2024
ABP-671
"Participants who were randomized to any of the ABP-671 treatment groups in Part 1 or Part 2 of Study ABP-671-301 will continue to receive the same dose level and dosing regimen during the Treatment Period of this Extension Study.~Participants who were randomized to receive placebo in Part 1 or Part 2 of Study ABP-671-301 will receive ABP-671 during the Treatment Period of the Extension Study."
Allopurinol
Participants who were randomized to receive allopurinol in Part 1 of Study ABP-671-301 will continue to receive allopurinol during the Treatment Period of the Extension Study.
Chang Gung Memorial Hospital CGMH, Kaohsiung City
Emeritus Research Sydney, Botany
Paratus Clinical Research Western Sydney, Blacktown
Paratus Clinical Research Central Coast, Kanwal
Austin Health - Repatriation Hospital, Heidelberg
Emeritus Research Melbourne, Camberwell
A R Houston Medical Pty Ltd, Kippa-Ring
Altoona Center for Clinical Research, Duncansville
Annapolis Internal Medicine/CCT Research, Annapolis
OnSite Clinical Solutions, Salisbury
Advanced Clinical Research of Atlanta, Atlanta
Centricity Research, Columbus
Jacksonville Center for Clinical Research, Jacksonville
Accel Clinical Research Site, DeLand
Combined Research Orlando Phase I-IV, Orlando
A & D Doctor Center, Miami
Bioclinical Research Alliance, Miami
Cordova Research Institute, Miami
New Horizons Research, Palmetto Bay
Century Research LLC, Miami
ITB Research, Miami
JY Research Institute Inc., Cutler Bay
Nature Coast Clinical Reasearch, Crystal River
Access Research Institute, Brooksville
ClinSearch, Chattanooga
Medical Care/CCT, Elizabethton
DelRicht Research of Gulfport, Gulfport
Buddhist Dalin Tzu Chi General Hospital, Chiayi City
Alliance for Multispecialty Research, LLC., Newton
Quality Clinical Research, Inc, Omaha
DelRicht Research, New Orleans
AMR, New Orleans
Quality Research Inc., San Antonio
Worldwide Clinical Trials, San Antonio
PanAmerican Clinical Research, LLC, Brownsville
Alliance for Multispecialty Research, Tempe
Tucson Neuroscience Research, LLC, Tucson
Inspire Santa Fe Medical Group, Santa Fe
Santa Rosa Medical Center, Las Vegas
Anaheim Clinical Trials (Cenexel ACT), Anaheim
Center for Clinical Trials of Sacramento, Sacramento
Cheng-Shin General Hospital, Taipei
Chang Gung Memorial Hospital LinKou, Taoyuan District
Chung Shan Medical Univ. Hospital, Taichung
New Hospitals, Tbilisi
Evex Hospitals Caraps Medline, Tbilisi
Aversi Clini, Tbilisi
The First Medical Center, Tbilisi
Academician Vakhtang Bochorishvili Clinic, Tbilisi
Innova, Tbilisi
Clinical Research Center (CRC), Guatemala City
Clínica Médica Especializada en Medicina Interna y Reumatología (CREER), Guatemala City
Clínica Médica Especializada en Medicina Interna y Reumatología, Guatemala City
Clínica Médica Especializada en Medicina Interna, Guatemala City
Lead Sponsor
Atom Therapeutics Co., Ltd
INDUSTRY